Venclexta and Oxaliplatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Venclexta (venetoclax) and Oxaliplatin (oxaliplatin). Common drug interactions include nodule among females and disease progression among males.

The phase IV clinical study analyzes what interactions people have when they take Venclexta and Oxaliplatin. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Venclexta?

Venclexta has active ingredients of venetoclax. eHealthMe is studying from 31,425 Venclexta users. Check the latest studies of Venclexta.

What is Oxaliplatin?

Oxaliplatin has active ingredients of oxaliplatin. It is often used in colon cancer. eHealthMe is studying from 72,058 Oxaliplatin users. Check the latest studies of Oxaliplatin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 28, 2026

11 people who take Venclexta and Oxaliplatin together, and have interactions are studied.

Venclexta and Oxaliplatin drug interactions.

What are the common drug interactions of Venclexta and Oxaliplatin, by gender? *:

female:

  1. Nodule (a growth of abnormal tissue)
  2. Peripheral swelling
  3. Arthralgia (joint pain)
  4. Back pain
  5. Haematocrit decreased
  6. Haemoglobin decreased
  7. Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
  8. Platelet count decreased
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Cough

male:

  1. Disease progression
  2. Jc virus infection
  3. Mantle cell lymphoma recurrent (cancer of lymphocytes, a type of white blood cell- recurrent)
  4. Pyrexia (fever)
  5. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  6. Death
  7. Optic disc disorder (disease of optic disc of eye)

What are the common drug interactions of Venclexta and Oxaliplatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Death
  2. Disease progression

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Arthralgia (joint pain)
  3. Back pain
  4. Fatigue (feeling of tiredness)
  5. Haematocrit decreased
  6. Haemoglobin decreased
  7. Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
  8. Platelet count decreased
  9. Disease progression
  10. Jc virus infection

60+:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Cough
  3. Nodule (a growth of abnormal tissue)
  4. Peripheral swelling
  5. Skin lesion
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Xerophthalmia (eye fails to produce tears)
  8. Coma (state of unconsciousness lasting more than six hours)
  9. Death
  10. Pneumonia

What are the existing conditions these people have? *

  1. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 45.45%
  2. Mantle Cell Lymphoma Refractory (relapsed cancer of lymphocytes, a type of white blood cell): 3 people, 27.27%
  3. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 27.27%
  4. High Blood Pressure: 3 people, 27.27%
  5. Fever: 3 people, 27.27%
  6. Pain: 2 people, 18.18%
  7. Nausea (feeling of having an urge to vomit): 2 people, 18.18%
  8. Sinusitis (inflammation of sinus): 1 person, 9.09%
  9. Ruptured Eardrum (tear in eardrum): 1 person, 9.09%
  10. Rashes (redness): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Venclexta and Oxaliplatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Venclexta and Oxaliplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Venclexta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxaliplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Venclexta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxaliplatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on venetoclax and oxaliplatin (the active ingredients of Venclexta and Oxaliplatin, respectively), and Venclexta and Oxaliplatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: